Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Tirosint - Sol
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Subpotent Drug
What was recalled
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0135-5
- Recalling firm
- Ibsa Pharma INC
- NDC code
- 71858-0135-5
- Origin
- NJ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0342-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Levothyroxine recalls
See all
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.